Issa Nidal, Murninkas Alejandro, Schmilovitz-Weiss Hemda, Agbarya Abed, Powsner Eldad
1 Department of Surgery B, Rabin Medical Center , Petah-Tikva, Israel .
2 Sackler School of Medicine, Tel-Aviv University , Tel Aviv, Israel .
J Laparoendosc Adv Surg Tech A. 2015 Aug;25(8):617-24. doi: 10.1089/lap.2014.0647. Epub 2015 May 27.
Radical rectal resection following neoadjuvant chemoradiation therapy (CRT) for locally advanced rectal cancer is accompanied by relatively high morbidity. Local excision of rectal cancer may be more appropriate for some frail patients with severe comorbidities. Transanal endoscopic microsurgery (TEM), consisting of local excision of selected rectal cancers, has been associated with low rates of postoperative complications. Because neoadjuvant CRT for rectal cancer may be associated with increased complications, the suitability of TEM following CRT is still unclear. In this study we aimed to assess the clinical outcomes of patients undergoing TEM following neoadjuvant CRT.
This study retrospectively analyzed all patients undergoing TEM for malignant rectal tumor in our institution between 2004 and 2010. They were divided into those who received CRT (CRT group) and those without CRT (non-CRT group). Demographics and clinical data were compared.
Forty-four of 97 patients who underwent TEM were included: 13 CRT and 31 non-CRT. Age, comorbidities, and the duration of the procedure were similar for both groups. There were no significant group differences in tumor diameter (2.1 cm [range, 0.5-3.5 cm] and 2.9 cm [range, 0.5-4.2 cm], respectively; P=.125) or distance of the lower part of the tumor from the anal verge (6.7 cm [range, 5-10 cm] and 7.7 cm [range, 5-15 cm], respectively; P=.285). Two non-CRT patients had peritoneal entry, and 1 of them underwent protective ileostomy because of insecure rectal defect closure. One non-CRT patient underwent a re-operation for postoperative bleeding. The other perioperative complications were minor and included urinary retention requiring catheter placement (2 patients in each group), pulmonary edema (1 non-CRT patient), and pneumonia (1 non-CRT patient). All complications were managed conservatively. There was no wound disruption, major complication, or mortality in either group.
With proper patient selection, TEM can be performed safely following CRT, without major complication or increased postoperative morbidity.
局部晚期直肠癌新辅助放化疗(CRT)后行根治性直肠切除术的发病率相对较高。对于一些伴有严重合并症的体弱患者,局部切除直肠癌可能更为合适。经肛门内镜显微手术(TEM),即对选定的直肠癌进行局部切除,其术后并发症发生率较低。由于直肠癌新辅助CRT可能会增加并发症,CRT后TEM的适用性仍不明确。在本研究中,我们旨在评估新辅助CRT后接受TEM的患者的临床结局。
本研究回顾性分析了2004年至2010年间在我院接受TEM治疗恶性直肠肿瘤的所有患者。他们被分为接受CRT的患者(CRT组)和未接受CRT的患者(非CRT组)。比较了人口统计学和临床数据。
97例行TEM的患者中有44例被纳入研究:13例CRT组和31例非CRT组。两组患者的年龄、合并症和手术时间相似。两组在肿瘤直径(分别为2.1 cm[范围,0.5 - 3.5 cm]和2.9 cm[范围,0.5 - 4.2 cm];P = 0.125)或肿瘤下部距肛缘的距离(分别为6.7 cm[范围,5 - 10 cm]和7.7 cm[范围,5 - 15 cm];P = 0.285)方面无显著组间差异。2例非CRT患者发生腹腔进入,其中1例因直肠缺损闭合不牢固而接受了保护性回肠造口术。1例非CRT患者因术后出血接受了再次手术。其他围手术期并发症较轻,包括需要留置导尿管的尿潴留(每组2例患者)、肺水肿(1例非CRT患者)和肺炎(1例非CRT患者)。所有并发症均经保守治疗。两组均未发生伤口裂开、严重并发症或死亡。
经过适当的患者选择,CRT后可安全地进行TEM,无严重并发症或术后发病率增加。